Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
New Directions for Mental Health Services
|
January 1, 1989
The evolution of Oregon's Public Psychiatry Training Program
J D Bloom, D L Cutler, L R Faulkner, et al.
Journal of Clinical Pharmacology
|
October 12, 1999
Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function
S R Andersen, L J Lambrecht, S K Swan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 11, 1998
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8
L L Reznikov, A J Puren, G Fantuzzi, et al.
Blood
|
January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, S M O'Connell, et al.
Pharmaceutical Research
|
January 6, 2001
Population pharmacokinetics of temozolomide in cancer patients
J F Jen, D L Cutler, S M Pai, et al.
Journal of Clinical Pharmacology
|
September 1, 1995
Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor
F T Aweeka, M Mak, A al-Uzri, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1992
Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia
G R Freidenberg, D L Cutler, M C Jones, et al.
Blood
|
April 15, 1997
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
D Pajkrt, T van der Poll, M Levi, et al.
The American Journal of Psychiatry
|
October 1, 1989
A basic residency curriculum concerning the chronically mentally ill
L R Faulkner, D L Cutler, D D Krohn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
A Awada, F A L M Eskens, M Piccart, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
New Directions for Mental Health Services
|
January 1, 1989
The evolution of Oregon's Public Psychiatry Training Program
J D Bloom, D L Cutler, L R Faulkner, et al.
Journal of Clinical Pharmacology
|
October 12, 1999
Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function
S R Andersen, L J Lambrecht, S K Swan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 11, 1998
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8
L L Reznikov, A J Puren, G Fantuzzi, et al.
Blood
|
January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, S M O'Connell, et al.
Pharmaceutical Research
|
January 6, 2001
Population pharmacokinetics of temozolomide in cancer patients
J F Jen, D L Cutler, S M Pai, et al.
Journal of Clinical Pharmacology
|
September 1, 1995
Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor
F T Aweeka, M Mak, A al-Uzri, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1992
Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia
G R Freidenberg, D L Cutler, M C Jones, et al.
Blood
|
April 15, 1997
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
D Pajkrt, T van der Poll, M Levi, et al.
The American Journal of Psychiatry
|
October 1, 1989
A basic residency curriculum concerning the chronically mentally ill
L R Faulkner, D L Cutler, D D Krohn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
A Awada, F A L M Eskens, M Piccart, et al.
Page
of 6